Syntheses and Antiproliferative Activities of Novel Diarylthiosemicarbazide Derivatives

doi:10.1007/s40242-013-2136-5

Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (1): 62-66.doi: 10.1007/s40242-013-2136-5

Previous Articles Next Articles

Syntheses and Antiproliferative Activities of Novel Diarylthiosemicarbazide Derivatives

ZHAI Xin, HE Ying, YANG Zhen, GONG Ping

Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China

Received:2012-04-05 Revised:2012-05-15 Online:2013-02-01 Published:2013-01-23
Supported by:
Supported by the National Natural Science Foundation of China(No.21002065) and the Science & Technology Project of Liaoning Province, China(No.LJQ201107).

Abstract

Abstract:

A series of novel N-methylpicolinamide-moiety containing diarylthiosemicarbazide derivatives was prepared and evaluated for their in vitro antiproliferative activity against three cancer cell lines(human alveolar epithelial cell A549, human lung cancer cell H460 and human colorectal cancer cell HT-29) by 3-(4,5-dimethyl)thiazolyl-diphenyltetrazoliumromide(MTT) assay. Six compounds(7b―7g) with halogen substituents exhibited preferable cytotoxicity against one or more cell lines in a low micromolar range. Especially, the most promising compound 7g exhibited remarkable antiproliferative activity with the IC50 values of 2.2, 1.8 and 5.2 μmol/L against A549, H460 and HT-29 cell lines respectively, which is comparable to sorafenib.

Key words:

Thiosemicarbazide, N-methylpicolinamide, Antiproliferative activity

ZHAI Xin, HE Ying, YANG Zhen, GONG Ping. Syntheses and Antiproliferative Activities of Novel Diarylthiosemicarbazide Derivatives[J]. Chemical Research in Chinese Universities, 2013, 29(1): 62-66.

References

[1] Zhai X., Zhang C. L., He L., Li Q., Wang J. L. Shen X. L., Gong P., Chem. Res. Chinese Universit#em/em#es, 2009, 25(4), 474

[2] Jiang N., Zhai X., Chen Z. C., Liang C., Sun C., Gong P., Chem. Pharm. Bull., 2012, 60, 659

[3] Guo S. C., Zhao Y. F., Li R. D., Xie L. J., Yang Y. B., Gong P., Chem. Res. Chinese Universit#em/em#es, 2008, 24(1), 47

[4] Richard M., J. Med. Chem., 2010, 53, 1413

[5] Liu L., Cao Y., Zhang X., McNabola A., Wilkie D., Wilhelm S., Lynch M., Carter C., Cancer Res., 2006, 66, 11851

[6] Yao P., Xue H., Liu Q., Liu H. T., Chen M. J., Gong P., Chem. Res. Chinese Universit#em/em#es, 2010, 26(4), 558

[7] Yao P., Zhai X., Liu D., Qi B. H., Tan H. L., Jin Y. C., Gong P., Arch. Pharm., 2008, 343, 17

[8] Potashman M. H., Bready J., Coxon A., Demelfi T., Dipietro L., Doerr N., Elbaum D., Estrada J., Gallant P., Germain J., Gu Y., Harmange J., Kaufman S., Kendall R., Kim J., Kumar G., Long A., Neervannan S., Patel V., Polverino A., Rose P., Plas S., Whittington D., Zanon R., Zhao H., J. Med. Chem., 2007, 50, 4351

[9] Ramurthy S., Subramanian S., Aikawa M., Amiri P., Costales A., J. Med. Chem., 2008, 51, 7049

[10] Dai Y., Hartandi K., Ji Z., Ji Z., Ahmed A., Albert D., Bauch J., Bouska J., Bousquet P., Cunha G., Glaser K., Harris C., Hickman D., Guo J., Li J., Marcotte P., Marsh K., Moskey M., Martin R., Olson A., Osterling D., Pease L., Soni N., Stewart K., Stoll V., Tapang P., Reuter D., Davidsen S., Michaelides M., J. Med. Chem., 2007, 50, 1584

[11] Li W. Zhai X. Zhong Z., Li G., Pu Y., Gong P., Arch. Pharm., 2011, 344, 349

[12] Bankston D., Dumas J., Natero R., Riedl B., Monahan M., Sibley R., Org. Process Res. Dev., 2002, 6, 777

[13] Sonawane N., Verkman A., Bioorg. Med. Chem., 2008, 16, 8187

[14] Khanfar M., Hill R., Kaddoumi A., Kaddoumi A., Sayed K., J. Med. Chem., 2011, 53, 8534

[15] Ragab F., Sayed N., Eissa A., Kerdawy A., Chem. Pharm. Bull., 2010, 58, 1148

Syntheses and Antiproliferative Activities of Novel Diarylthiosemicarbazide Derivatives

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments